-
-
-
-
-
-
-
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
-
-
-
-
-
-
-
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
-
-
-
1,185,399 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

